Details for: DARS1
Gene ID: 1615
Gene Type: Protein-coding - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.
Symbol: DARS1
Ensembl ID: ENSG00000115866
Description: aspartyl-tRNA synthetase 1
Selected Context(s): Overall
Cell Significance Landscape
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 34.75rCSI 42.99%PRS 17.02
-
CSI 28.54rCSI 18.97%PRS 23.25
-
CSI 28.03rCSI 25.31%PRS 17.45
-
CSI 25.59rCSI 20.69%PRS 19.43
-
CSI 15.14rCSI 23.39%PRS 18.19
-
CSI 13.01rCSI 20.69%PRS 16.38
-
CSI 12.6rCSI 17.18%PRS 10.44
-
CSI 12.35rCSI 21.89%PRS 15.91
-
CSI 10.48rCSI 39.26%PRS 16.37
-
CSI 10.26rCSI 7.91%PRS 17.96
-
CSI 9.59rCSI 42.17%PRS 18.27
-
CSI 8.02rCSI 18.7%PRS 44.29
-
CSI 7.58rCSI 24.31%PRS 27.81
-
CSI 7.44rCSI 38.44%PRS 37.57
-
CSI 7.42rCSI 14.02%PRS 24.48
-
CSI 6.93rCSI 6.67%PRS 20.09
-
CSI 6.68rCSI 38.89%PRS 28.81
-
CSI 5.64rCSI 20.01%PRS 31.48
-
CSI 5.49rCSI 7.3%PRS 21.26
-
CSI 5.04rCSI 3.39%PRS 23.73
-
CSI 5.01rCSI 27.03%PRS 33.92
-
CSI 4.89rCSI 6.68%PRS 30.38
-
CSI 4.85rCSI 6.17%PRS 22.54
-
CSI 4.84rCSI 5.05%PRS 20.22
-
CSI 4.55rCSI 8.85%PRS 19.85
-
CSI 4.21rCSI 12.03%PRS 32.88
-
CSI 4.14rCSI 3.09%PRS 32.56
-
CSI 3.65rCSI 9.51%PRS 17.9
-
CSI 3.35rCSI 7.67%PRS 18.85
-
CSI 3.28rCSI 78.53%PRS 9.78
-
CSI 3.25rCSI 2.74%PRS 30.78
-
CSI 3.18rCSI 3.13%PRS 21
-
CSI 3.13rCSI 75.54%PRS 10.73
-
CSI 2.99rCSI 42.44%PRS 14.65
-
CSI 2.84rCSI 8.39%PRS 23.37
-
CSI 2.7rCSI 4.02%PRS 23.17
-
CSI 2.67rCSI 1.58%PRS 27.11
-
CSI 2.6rCSI 4.96%PRS 42.45
-
CSI 2.53rCSI 12.59%PRS 20.94
-
CSI 2.51rCSI 4.1%PRS 11.12
-
CSI 2.44rCSI 9.5%PRS 31.84
-
CSI 2.43rCSI 5.38%PRS 17.96
-
CSI 2.3rCSI 46.86%PRS 16.55
-
CSI 2.3rCSI 1.6%PRS 27.4
-
CSI 2.29rCSI 46.74%PRS 15.52
-
CSI 2.29rCSI 11.29%PRS 26.3
-
CSI 2.17rCSI 5.08%PRS 27.95
-
CSI 2.08rCSI 11.91%PRS 29.13
-
CSI 2.08rCSI 2.78%PRS 21.31
-
CSI 1.98rCSI 7.98%PRS 17.52
-
CSI 1.94rCSI 4.29%PRS 13.92
-
CSI 1.91rCSI 1.68%PRS 22.3
-
CSI 1.9rCSI 3.66%PRS 43.3
-
CSI 1.86rCSI 3.54%PRS 30.68
-
CSI 1.86rCSI 20.34%PRS 34.43
-
CSI 1.76rCSI 2.43%PRS 27.44
-
CSI 1.75rCSI 2.73%PRS 44.12
-
CSI 1.73rCSI 1.61%PRS 19.47
-
CSI 1.71rCSI 2.5%PRS 22.28
-
CSI 1.67rCSI 2.41%PRS 27.1
-
CSI 1.65rCSI 1.85%PRS 30.96
-
CSI 1.59rCSI 1.41%PRS 19.54
-
CSI 1.58rCSI 1.11%PRS 45.29
-
CSI 1.57rCSI 1.36%PRS 21.82
-
CSI 1.56rCSI 5.56%PRS 56.49
-
CSI 1.52rCSI 1.22%PRS 34.54
-
CSI 1.51rCSI 2.06%PRS 44.93
-
CSI 1.51rCSI 3.88%PRS 25.27
-
CSI 1.48rCSI 2.43%PRS 14.94
-
CSI 1.46rCSI 1.57%PRS 17.88
-
CSI 1.43rCSI 7.15%PRS 25.63
-
CSI 1.37rCSI 1.14%PRS 18.38
-
CSI 1.35rCSI 8.35%PRS 56.79
-
CSI 1.35rCSI 1.56%PRS 17.02
-
CSI 1.34rCSI 4.86%PRS 33.21
-
CSI 1.32rCSI 1.26%PRS 39.18
-
CSI 1.31rCSI 1.67%PRS 22.45
-
CSI 1.28rCSI 2.92%PRS 16.67
-
CSI 1.27rCSI 2.94%PRS 15.65
-
CSI 1.27rCSI 23.21%PRS 53.31
-
CSI 1.25rCSI 1.44%PRS 39.16
-
CSI 1.25rCSI 0.87%PRS 23.19
-
CSI 1.21rCSI 2.66%PRS 29.45
-
CSI 1.19rCSI 2.14%PRS 17.97
-
CSI 1.19rCSI 1.24%PRS 19.88
-
CSI 1.14rCSI 1.75%PRS 31.37
-
CSI 1.11rCSI 2.35%PRS 30.86
-
CSI 1.09rCSI 2.85%PRS 29.53
-
CSI 1.08rCSI 0.82%PRS 26.58
-
CSI 1.08rCSI 1.48%PRS 21.97
-
CSI 1.08rCSI 2.24%PRS 19.36
-
CSI 1.07rCSI 0.83%PRS 18.59
-
CSI 1.05rCSI 2.1%PRS 14.37
-
CSI 1.04rCSI 0.72%PRS 20.62
-
CSI 1.04rCSI 1.26%PRS 24.36
-
CSI 1.03rCSI 5.27%PRS 19.82
-
CSI 1.03rCSI 1.58%PRS 26.63
-
CSI 1.02rCSI 1.66%PRS 19.59
-
CSI 1.02rCSI 3.66%PRS 10.78
-
CSI 1.01rCSI 2.92%PRS 21.94
-
CSI -3.9rCSI -4.6%PRS 26.5%
-
CSI -2.5rCSI -4.1%PRS 11.5%
-
CSI -1.9rCSI -3.9%PRS 41.8%
-
CSI -1.8rCSI -3.7%PRS 28.8%
-
CSI -1.3rCSI -4.0%PRS 15.3%
-
CSI -1.0rCSI -1.6%PRS 12.5%
-
CSI -0.7rCSI -1.3%PRS 11.4%
-
CSI -0.4rCSI -0.4%PRS 34.9%
-
CSI -0.3rCSI -0.8%PRS 29.4%
-
CSI -0.3rCSI -0.7%PRS 11.3%
-
CSI -0.1rCSI -0.3%PRS 29.0%
-
CSI 0.0rCSI 0.0%PRS 37.5%
-
CSI 0.0rCSI 0.0%PRS 16.2%
-
CSI 0.1rCSI 0.7%PRS 55.3%
-
CSI 0.1rCSI 0.4%PRS 15.1%
-
CSI 0.1rCSI 0.2%PRS 34.5%
-
CSI 0.1rCSI 2.1%PRS 52.6%
-
CSI 0.1rCSI 0.9%PRS 9.4%
-
CSI 0.1rCSI 2.0%PRS 81.9%
-
CSI 0.1rCSI 1.2%PRS 36.8%
-
CSI 0.1rCSI 0.4%PRS 12.2%
-
CSI 0.1rCSI 0.2%PRS 36.8%
-
CSI 0.1rCSI 0.2%PRS 20.6%
-
CSI 0.1rCSI 1.1%PRS 35.3%
-
CSI 0.2rCSI 0.2%PRS 20.6%
-
CSI 0.2rCSI 0.4%PRS 30.7%
-
CSI 0.2rCSI 0.3%PRS 38.6%
-
CSI 0.2rCSI 0.5%PRS 20.4%
-
CSI 0.2rCSI 0.6%PRS 33.7%
-
CSI 0.2rCSI 0.3%PRS 19.5%
-
CSI 0.2rCSI 0.5%PRS 25.1%
-
CSI 0.2rCSI 0.5%PRS 18.1%
-
CSI 0.2rCSI 0.4%PRS 40.9%
-
CSI 0.2rCSI 1.1%PRS 10.4%
-
CSI 0.2rCSI 0.6%PRS 13.2%
-
CSI 0.2rCSI 3.5%PRS 65.1%
-
CSI 0.2rCSI 0.6%PRS 14.9%
-
CSI 0.2rCSI 0.6%PRS 19.4%
-
CSI 0.2rCSI 0.3%PRS 33.5%
-
CSI 0.2rCSI 2.5%PRS 72.7%
-
CSI 0.2rCSI 0.6%PRS 14.7%
-
CSI 0.2rCSI 0.4%PRS 25.5%
-
CSI 0.2rCSI 0.7%PRS 44.2%
-
CSI 0.2rCSI 1.0%PRS 33.2%
-
CSI 0.2rCSI 0.6%PRS 30.9%
-
CSI 0.2rCSI 1.1%PRS 33.7%
-
CSI 0.3rCSI 0.3%PRS 14.3%
-
CSI 0.3rCSI 0.6%PRS 22.4%
-
CSI 0.3rCSI 1.2%PRS 40.0%
-
CSI 0.3rCSI 0.4%PRS 19.5%
-
CSI 0.3rCSI 1.0%PRS 18.9%
-
CSI 0.3rCSI 0.3%PRS 11.3%
-
CSI 0.3rCSI 0.6%PRS 20.0%
-
CSI 0.3rCSI 0.4%PRS 17.2%
-
CSI 0.3rCSI 0.2%PRS 34.3%
-
CSI 0.3rCSI 0.2%PRS 30.3%
-
CSI 0.3rCSI 2.1%PRS 11.3%
-
CSI 0.3rCSI 0.4%PRS 18.0%
-
CSI 0.3rCSI 1.0%PRS 64.2%
-
CSI 0.3rCSI 1.0%PRS 16.8%
-
CSI 0.3rCSI 0.5%PRS 33.9%
-
CSI 0.3rCSI 0.6%PRS 50.6%
-
CSI 0.3rCSI 0.4%PRS 29.8%
-
CSI 0.3rCSI 0.5%PRS 15.1%
-
CSI 0.3rCSI 0.5%PRS 26.3%
-
CSI 0.3rCSI 0.4%PRS 19.0%
-
CSI 0.3rCSI 0.9%PRS 31.8%
-
CSI 0.3rCSI 1.8%PRS 56.3%
-
CSI 0.3rCSI 0.5%PRS 23.2%
-
CSI 0.3rCSI 1.0%PRS 36.1%
-
CSI 0.3rCSI 0.7%PRS 37.6%
-
CSI 0.3rCSI 0.5%PRS 29.1%
-
CSI 0.3rCSI 0.8%PRS 12.3%
-
CSI 0.4rCSI 0.5%PRS 19.6%
-
CSI 0.4rCSI 0.7%PRS 13.9%
-
CSI 0.4rCSI 4.0%PRS 62.2%
-
CSI 0.4rCSI 1.1%PRS 41.3%
-
CSI 0.4rCSI 0.4%PRS 28.2%
-
CSI 0.4rCSI 1.7%PRS 35.7%
-
CSI 0.4rCSI 1.8%PRS 38.6%
-
CSI 0.4rCSI 0.7%PRS 29.6%
-
CSI 0.4rCSI 0.4%PRS 22.9%
-
CSI 0.4rCSI 1.4%PRS 59.5%
-
CSI 0.4rCSI 0.4%PRS 21.9%
-
CSI 0.4rCSI 1.8%PRS 59.7%
-
CSI 0.4rCSI 0.7%PRS 22.9%
-
CSI 0.4rCSI 0.4%PRS 20.7%
-
CSI 0.4rCSI 0.6%PRS 26.7%
-
CSI 0.4rCSI 0.7%PRS 21.3%
-
CSI 0.4rCSI 0.4%PRS 22.7%
-
CSI 0.4rCSI 4.1%PRS 50.2%
-
CSI 0.4rCSI 0.6%PRS 30.6%
-
CSI 0.4rCSI 2.5%PRS 12.0%
-
CSI 0.4rCSI 2.3%PRS 22.8%
-
CSI 0.4rCSI 1.2%PRS 30.0%
-
CSI 0.5rCSI 0.4%PRS 28.4%
-
CSI 0.5rCSI 0.8%PRS 29.9%
-
CSI 0.5rCSI 1.9%PRS 40.7%
-
CSI 0.5rCSI 1.0%PRS 9.7%
-
CSI 0.5rCSI 0.4%PRS 14.1%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 4130057107
Symbol: SYDC_HUMAN
Name: Aspartyl-tRNA synthetase
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 2674137
Title: cDNA sequence, predicted primary structure, and evolving amphiphilic helix of human aspartyl-tRNA synthetase.
PubMed ID: 2674137
PubMed ID: 14702039
Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.
PubMed ID: 14702039
DOI: 10.1038/ng1285
PubMed ID: 17974005
Title: The full-ORF clone resource of the German cDNA consortium.
PubMed ID: 17974005
PubMed ID: 15815621
Title: Generation and annotation of the DNA sequences of human chromosomes 2 and 4.
PubMed ID: 15815621
DOI: 10.1038/nature03466
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 14654843
Title: Proteomic characterization of the human centrosome by protein correlation profiling.
PubMed ID: 14654843
DOI: 10.1038/nature02166
PubMed ID: 18029264
Title: Lysyl-tRNA synthetase interacts with EF1alpha, aspartyl-tRNA synthetase and p38 in vitro.
PubMed ID: 18029264
PubMed ID: 19413330
Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.
PubMed ID: 19413330
DOI: 10.1021/ac9004309
PubMed ID: 19131329
Title: Dissection of the structural organization of the aminoacyl-tRNA synthetase complex.
PubMed ID: 19131329
PubMed ID: 19289464
Title: Dynamic Organization of Aminoacyl-tRNA Synthetase Complexes in the Cytoplasm of Human Cells.
PubMed ID: 19289464
PubMed ID: 19608861
Title: Lysine acetylation targets protein complexes and co-regulates major cellular functions.
PubMed ID: 19608861
PubMed ID: 21269460
Title: Initial characterization of the human central proteome.
PubMed ID: 21269460
PubMed ID: 21406692
Title: System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.
PubMed ID: 21406692
PubMed ID: 23643384
Title: Mutations in DARS cause hypomyelination with brain stem and spinal cord involvement and leg spasticity.
PubMed ID: 23643384
PubMed ID: 23186163
Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.
PubMed ID: 23186163
DOI: 10.1021/pr300630k
PubMed ID: 24275569
Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.
PubMed ID: 24275569
PubMed ID: 25944712
Title: N-terminome analysis of the human mitochondrial proteome.
PubMed ID: 25944712
PubMed ID: 23609930
Title: Crystal structure of human cytosolic aspartyl-tRNA synthetase, a component of multi-tRNA synthetase complex.
PubMed ID: 23609930
DOI: 10.1002/prot.24306
Sequence Information:
- Length: 501
- Mass: 57136
- Checksum: B181572DF0AF5F94
- Sequence:
MPSASASRKS QEKPREIMDA AEDYAKERYG ISSMIQSQEK PDRVLVRVRD LTIQKADEVV WVRARVHTSR AKGKQCFLVL RQQQFNVQAL VAVGDHASKQ MVKFAANINK ESIVDVEGVV RKVNQKIGSC TQQDVELHVQ KIYVISLAEP RLPLQLDDAV RPEAEGEEEG RATVNQDTRL DNRVIDLRTS TSQAVFRLQS GICHLFRETL INKGFVEIQT PKIISAASEG GANVFTVSYF KNNAYLAQSP QLYKQMCICA DFEKVFSIGP VFRAEDSNTH RHLTEFVGLD IEMAFNYHYH EVMEEIADTM VQIFKGLQER FQTEIQTVNK QFPCEPFKFL EPTLRLEYCE ALAMLREAGV EMGDEDDLST PNEKLLGHLV KEKYDTDFYI LDKYPLAVRP FYTMPDPRNP KQSNSYDMFM RGEEILSGAQ RIHDPQLLTE RALHHGIDLE KIKAYIDSFR FGAPPHAGGG IGLERVTMLF LGLHNVRQTS MFPRDPKRLT P